Search Site

Ajay J. Kirtane, MD, SM

  • Associate Professor of Medicine at CUMC
  • Director, NYP/Columbia Cardiac Catheterization Laboratories
  • Chief Academic Officer, Center for Interventional Vascular Therapy
Ajay J. Kirtane, MD, SM

Ajay J. Kirtane, MD, SM specializes in complex coronary and peripheral vascular interventional procedures and assumed the directorship of the New York-Presbyterian / Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association.

Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and additionally obtained a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health.

Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology. He is/has been Principal Investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

Dr. Kirtane was born in Brooklyn and grew up in Bergen County, NJ. In his free time, Dr. Kirtane has avid interests in running, tennis, skiing, and music.

Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He is/has been Principal Investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

Departments And Divisions

  • Department of Medicine
    Division of Cardiology

Board Certifications

  • Interventional Cardiology
  • Cardiovascular Disease

Areas of Expertise

  • Vascular Medicine
  • Interventional Cardiology
  • Transradial Catheterization
  • Endovascular Intervention
  • Peripheral Arterial Intervention
  • Renal Denervation for Hypertension
  • Stents

Education & Training

  • AB, Princeton University
  • 1998 Columbia University College of Physicians and Surgeons
  • MD, Columbia University College of Physicians and Surgeons
  • 2005 Harvard School of Public Health
  • SM, Harvard School of Public Health
  • Internship: University of California-San Francisco Medical Center
  • Residency: University of California-San Francisco Medical Center
  • Fellowship: Harvard Medical School/ Beth Israel Deaconess Medical Center

Locations

  • Herbert Irving Pavilion

    161 Fort Washington Avenue
    Floor: 6
    New York, NY 10032
    Phone:
    (212) 305-7060
    For new and current patient appointments, call:
    (212) 305-7060
    Fax:
    (212) 342-3660

Provider Affiliations

  • NewYork-Presbyterian/Columbia

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NY Signature, POS, PPO, Signature Administrators, Student Health]
  • Affinity [Access (Exchange), Essential Plan, Medicaid Managed Care, Medicare Managed Care]
  • Amida Care [Special Needs Plan]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Emblem/GHI [HMO, Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Medicare (Mediblue), NYP Employee Plan, Pathway (Exchange), POS, PPO]
  • Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
  • Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
  • Healthfirst [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
  • Local 1199 [Local 1199]
  • MagnaCare [MagnaCare]
  • Medicare [Traditional Medicare (NY)]
  • Multiplan [Multiplan]
  • Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]
  • POMCO [POMCO]
  • UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), EPO, Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care, SelectHealth]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

This provider accepts new patients

Appointment Phone Number: (212) 305-7060

Committees/Societies/Memberships

Columbia University Medical Center
2007-present Cardiovascular Disease Fellowship Selection Committee
2007-present Faculty Interviewer, Interventional Cardiology Fellowship
2010-present P&S Conflict of Interest Policy Committee on Education and Clinical Care
2010-present P&S Conflict of Interest Review Committee on Education and Clinical Care
2012-2013 Implementation of the Academic Tracks Committee, member of sub-committees on Clinical Focus
2012-2013 Academic Research Organization Initiative Working Group (Dean’s Working Group)
2012-2013 Cardiovascular Clinical Initiative's Working Group on Outcomes & Efficiency Studies and Databases
2012-2013 Cardiovascular Clinical Initiative's Working Group on Hypertension

New York-Presbyterian Hospital
2012-present ACC-PCI Database Quality Committee
2013-present Cardiac Catheterization Laboratory Inventory Committee

American College of Cardiology (ACC)
2009-present Abstract Grader, ACC Scientific Sessions/I2 Summit
2009-2011 i2 Summit Program Committee
2010-2012 Writing Group Member, Appropriate Use Criteria for Diagnostic Catheterization (ACC/SCAI)
2010-2012 Associate Editor (Interventional Cardiology Pathway) in CardioSource Lifelong Learning and MOC section
2011-2012 Member, NCDR Public Reporting Advisory Work Group
2011-2013 Challenging Case Reviewer, I2 Summit
2011-2015 ACC-i2 with TCT Program Committee
2011-2012 Co-Chair of Acute Coronary Syndromes Section on ACC Scientific Session Program Committee
2012 Expert Content Reviewer for CME/CNP Activities
2012-2013 Chair of Acute Coronary Syndromes Section on ACC Scientific Session Program Committee
2012-2015 TVT (Transcatheter Valve Therapy) Registry Research and Publications Subcommittee
2012-2014 Integrated Learning Committee, Core Member
2013-2015 Writing Committee for revision of the ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS) on a Task Force on Critical Care Cardiology
2015-present ACC.i2 Program Committee, Coronary Intervention: Application and Clinical Studies Team Lead
2015 Nominated Peer Reviewer: 2015 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

American Heart Association (AHA)
2008 Abstract Grader, Scientific Sessions
2009-2011 Member, Acute Cardiac Care and General Cardiology Committee, Council on Clinical Cardiology
2013 Steering Committee for the 2013 AHA Scientific Sessions Interventional Cardiology Track

Cardiovascular Research Foundation
2006 Transcatheter Cardiovascular Therapeutics Scientific Committee
2007-2012 Associate Director, Transcatheter Cardiovascular Therapeutics Conference
2013-present Co-Director, Transcatheter Cardiovascular Therapeutics Conference (4-5 day 12,000 person international meeting devoted to Interventional Cardiovascular Therapeutics)

Society of Cardiac Angiography and Interventions (SCAI)
2007 Abstract Grader, I2 Summit 2008
2010-2015 Member, Public Relations Committee
2011-2015 Member, Emerging Leadership Program Committee
2012 Invited Participant: Think Tank on Quality (2 invitation-only meetings)
2013-2014 Invited Peer Reviewer: 2013 ACCF/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014-2015 Abstract Grader, SCAI Annual Meeting
2013-present Mentor for the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Program (mentor to Sahil Parikh MD, and Dharam Kumbhani MD)

Association of American Medical Colleges (AAMC)
2013-2015 Columbia University College of Physicians and Surgeons Representative to the Association of American Medical Colleges Council of Faculty and Academic Societies (CFAS)

Honors & Awards

Columbia University Medical Center:
2009 Ewig Clinical Teaching Award (three-year funded award), Department of Medicine
2010 Daniel V. Kimberg Junior Faculty Teaching Award, Department of Medicine (given annually to a single recipient)
2011-present Selected to be a Firm Attending on the Neu Firm, Columbia University Department of Medicine
2012 Participant (by nomination/acceptance) in P&S Leadership & Management Institute sponsored by Columbia Doctors, The Columbia Faculty Practice Organization and the Office of the Dean at the College of P&S

American College of Cardiology:
2010 Selected as American College of Cardiology’s Emerging Faculty

Harvard Medical School:
2005 George E. Altman, M.D. and Harriet Altman Annual Cardiology Fellow Award

University of California San Francisco:
2000 Selected as Chief Medical Resident for 2001-2002 academic year

Columbia University College of Physicians and Surgeons:
1996 Gregory Grove Memorial Scholarship (given to the highest-ranking student in the second year class), co-recipient
1998 Externship in Human Rights and Medicine in India
1998 Marie Nercessian Memorial Award for Humanism in Medicine
1998 Membership in Alpha Omega Alpha Society

Princeton University:
1993 Howard Hughes Medical Institute Summer Fellowship
1994 E.R. Squibb and Sons Senior Thesis Prize for Contributions to Scientific Research
1994 Membership in Phi Beta Kappa Society
1994 Membership in Society of Sigma Xi

NIH Grants

  • A POST-APPROVAL STUDY OF THE MEDTRONIC RESOLUTE ONYX? ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM (RESOLUTE ONYX POST-APPROVAL STUDY) (P&S Industry Clinical Trial)

    Jun 13 2017 - Jun 13 2022

    OUTCOMES OF PERCUTANEOUS REVASCULARIZATION FOR MANAGEMENT OF SURGICALLY INELIGIBLE PATIEINTS WITH MULTIVESSEL OR LEFT MAIN CORONARY ARTERY DISEASE: A PROSPECTIVE REGISTRY (P&S Industry Clinical Trial)

    Apr 12 2017 - Apr 12 2022

    SERVICE AGREEMENT - MEDTRONIC - A 1197024 (C RDN) (P&S Industry Clinical Trial)

    Jan 14 2015 - Jan 14 2020

    THE USPELLA REGISTRY IS A MULTI-SITE, OBSERVATIONAL REGISTRY FOR COLLECTION OF DE-IDENTIFIED DATA FOR PATIENTS TREATED WITH THE IMPELLA ? 2.5 PERCUTANEOUS CARDIAC SUPPORT SYSTEM. (P&S Industry Clinical Trial)

    Oct 9 2013 - Oct 9 2018

    CALM-FIM_US CONTROLLING AND LOWERING BLOOD PRESSURE WITH THE MOBIUSHD A PROSPECTIVE MULTICENTER SAFETY STUDY (P&S Industry Clinical Trial)

    Jul 18 2013 - Jul 18 2018

    MEDTRONIC INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

    Jul 1 2017 - Jun 30 2018

    HYBRID CORONARY REVASCULARIZATION TRIAL (Federal Gov)

    Jul 15 2016 - Jun 30 2017

    COMPLEX HIGH-RISK INTERVENTIONAL PROCEDURES (Private)

    Jul 1 2016 - Jun 30 2017

    SIMPLICITY (P&S Industry Clinical Trial)

    Dec 15 2011 - Dec 15 2016

    CORONA FELLOWSHIP GRANT (Private)

    Jul 1 2015 - Jun 30 2016

    DEVELOPMENT OF A SHARED DECISION MAKING TOOL FOR PATIENTS CONSIDERING TRANSCATHETER AORTIC VALVE REPLACEMENT (Private)

    Jul 1 2015 - Jun 30 2016

    THE NEPHROTIC SYNDROME STUDY NETWORK (Private)

    Jul 1 2015 - Jun 30 2016

    MINI-AMI (P&S Industry Clinical Trial)

    Jun 17 2011 - Jun 17 2016

    DESERT: DRUG ELUTING STENT EVENT REGISTRY OF THEOMBOSIS ( THE NATIONAL DES THROMBOSIS REGISTRY) (P&S Industry Clinical Trial)

    Jan 19 2010 - Jan 19 2015

Publications

  1. Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-87.
  2. Kirtane AJ, King SB 3rd. Should all stent patients have prolonged dual antiplatelet therapy? JACC Cardiovasc Interv. 2015 May;8(6):873-5.
  3. Kirtane AJ, Kelly CR. Clearing the air on the "smoker's paradox". J Am Coll Cardiol. 2015 Mar 24;65(11):1116-8.
  4. Kirtane AJ, Stone GW. STEMI care in China: a world opportunity. Lancet. 2015 Jan 31;385(9966):400-1.
  5. Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH Jr, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE; ENDEAVOR IV Investigators. The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr;6(4):325-33.
  6. Kirtane AJ, Leon MB. The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective. Circulation. 2012 Jun 26;125(25):3229-32.
  7. Kirtane AJ, Stone GW. How to minimize stent thrombosis. Circulation. 2011 Sep 13;124(11):1283-7.
  8. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009 Jun 30;119(25):3198-206.
  9. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008 Feb 19;51(7):708-15.
  10. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med. 2008 Feb 5;148(3):234-8.
  11. Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9.
  12. Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18;45(2):321-3.

For a complete list of publications, please visit PubMed.gov